Experts share their knowledge of the elements of informed consent, IRB requirements, FDA regulations, the history of clinical investigations, and other key topics. Six of the most popular IRB sessions of DIA 2012 highlight emerging markets, CTTI, minimal risk research, rare diseases and ethics are offered for $299.

Sessions included:
165 Legal Jeopardy from the Conduct of Clinical Trials
166 Conducting Clinical Trials in Developing Countries: Challenges in Meeting Good Clinical Practice (GCP) Compliance
217 Update on Collaborative Projects of the Clinical Trials Transformation Initiative (CTTI)
256 Noninterventional Minimal Risk Research: A 360° Perspective
262 Understanding the Challenges of Conducting Studies for Orphan Indications and Rare Diseases
327 Applying Longstanding Ethical Principles in a Period of Dynamic Change